photo of Dr Freya Bruveris

Dr Freya Bruveris

Dr Freya Bruveris

Details

Role Project Manager
Research area Stem Cell Medicine
Dr Bruveris is currently the Project Manager of the Blood Disease, Blood Development and Immune Development Laboratories at the Murdoch Children's Research Institute. These laboratories are part of the of the recently established Novo Nordisk Foundation Centre for Stem Cell Medicine (reNEW), Melbourne Node.

After completing her PhD in Haematology at Monash University, Dr Bruveris took a postdoctoral research position training under Prof Andrew Elefanty and Prof Ed Stanley at the Murdoch Children's Research Institute in Melbourne, Australia. As a Stem Cell Biologist, she gained extensive knowledge of haematopoietic and endothelial differentiation, training in developmental haematopoiesis and vascular development and in vitro culture and manipulation of human pluripotent stem cells.
Dr Bruveris is currently the Project Manager of the Blood Disease, Blood Development and Immune Development Laboratories at the Murdoch Children's Research Institute. These laboratories are part of the of the recently established Novo Nordisk...
Dr Bruveris is currently the Project Manager of the Blood Disease, Blood Development and Immune Development Laboratories at the Murdoch Children's Research Institute. These laboratories are part of the of the recently established Novo Nordisk Foundation Centre for Stem Cell Medicine (reNEW), Melbourne Node.

After completing her PhD in Haematology at Monash University, Dr Bruveris took a postdoctoral research position training under Prof Andrew Elefanty and Prof Ed Stanley at the Murdoch Children's Research Institute in Melbourne, Australia. As a Stem Cell Biologist, she gained extensive knowledge of haematopoietic and endothelial differentiation, training in developmental haematopoiesis and vascular development and in vitro culture and manipulation of human pluripotent stem cells.

Top Publications

  • Bruveris, FF, Ng, ES, Stanley, EG, Elefanty, AG. VEGF, FGF2, and BMP4 regulate transitions of mesoderm to endothelium and blood cells in a human model of yolk sac hematopoiesis. Experimental Hematology 103: 30 -39.e2 2021
    view publication
  • Bruveris, FF, Ng, ES, Leitoguinho, AR, Motazedian, A, Vlahos, K, Sourris, K, Mayberry, R, McDonald, P, Azzola, L, Davidson, NM, et al. Human yolk sac-like haematopoiesis generates RUNX1-, GFI1- and/or GFI1B-dependent blood and SOX17-positive endothelium. Development 147(20) : dev193037 2020
    view publication
  • Motazedian, A, Bruveris, FF, Kumar, SV, Schiesser, JV, Chen, T, Ng, ES, Chidgey, AP, Wells, CA, Elefanty, AG, Stanley, EG. Multipotent RAG1+ progenitors emerge directly from haemogenic endothelium in human pluripotent stem cell-derived haematopoietic organoids. Nature Cell Biology 22(1) : 60 -73 2020
    view publication
  • Bruveris, FF, Ng, ES, Leitoguinho, AR, Motazedian, A, Vlahos, K, Sourris, K, Mayberry, R, McDonald, P, Azzola, L, Davidson, NM, et al. Human yolk sac-like haematopoiesis generates RUNX1- and GFI1/1B-dependent blood and SOX17-positive endothelium.. Development 2020
    view publication
  • Vlahos, K, Sourris, K, Mayberry, R, McDonald, P, Bruveris, FF, Schiesser, JV, Bozaoglu, K, Lockhart, PJ, Stanley, EG, Elefanty, AG. Generation of iPSC lines from peripheral blood mononuclear cells from 5 healthy adults. Stem Cell Research 34: 101380 2019
    view publication

Page 1 of 4

Career information